FREE NCPD | ILNA
ONCC ILNA Category:
Cellular Collection, Preparative Regimens, and Infusion (BMTCN®)
Learn more about myelofibrosis risks, novel therapies to slow disease progression and reduce symptoms and strategies to maintain quality of life in this comprehensive activity presented by John Mascarenhas, MD, Professor of Medicine at Mount Sinai Icahn School of Medicine. Start the activity now!
Studies have shown that certain cancer therapies adversely affect the heart and lead to various types of injuries, which often result in death. This activity reviews recent advances in the management of cancer teatment-induced cardiotoxicity.